HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Novel compound heterozygous mutations in DYNC2H1 in a patient with severe short-rib polydactyly syndrome type III phenotype.

Abstract
Short-rib polydactyly syndrome type III is an autosomal recessive lethal skeletal ciliopathy, which is phenotypically similar to nonlethal asphyxiating thoracic dystrophy. Mutations in DYNC2H1 have been identified in both of these disorders, indicating that they are variants of a single disorder. However, short-rib polydactyly syndrome type III is the more severe variant. Here, we report novel compound heterozygous mutations in DYNC2H1 (p.E1894fsX10 and p.R3004C) in a patient with typical short-rib polydactyly syndrome type III phenotype. R3004 is located within the microtubule-binding domain of DYNC2H1, and its substitution is predicted to disrupt the interaction with microtubules. Considering the severe phenotype of our patient, our findings suggest that R3004 may be a key residue for the microtubule-binding affinity of dynein.
AuthorsToshio Okamoto, Ken Nagaya, Yumi Kawata, Hiroko Asai, Etsushi Tsuchida, Fumikatsu Nohara, Kazuki Okajima, Hiroshi Azuma
JournalCongenital anomalies (Congenit Anom (Kyoto)) Vol. 55 Issue 3 Pg. 155-7 (Aug 2015) ISSN: 1741-4520 [Electronic] Australia
PMID25410398 (Publication Type: Case Reports, Journal Article)
Copyright© 2014 Japanese Teratology Society.
Chemical References
  • DYNC2H1 protein, human
  • Cytoplasmic Dyneins
Topics
  • Cytoplasmic Dyneins (genetics)
  • Heterozygote
  • Humans
  • Infant, Newborn
  • Male
  • Mutation (genetics)
  • Phenotype
  • Short Rib-Polydactyly Syndrome (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: